VP, Engineering
Fleetio- Full Time
- Expert & Leadership (9+ years)
Cardiosense is a rapidly growing, venture-backed medical AI company focused on redefining heart disease detection, monitoring, and management. We develop novel wearable sensors and advanced machine learning algorithms to provide clinically actionable digital biomarkers. Our team combines expertise in data science, biosignal analysis, and medicine to combat preventable cardiac disease. Cardiosense’s solutions are built on a decade of clinical research and collaboration with leading academic institutions.
Cardiosense is a rapidly growing, venture-backed medical AI company. We are dedicated to developing innovative solutions for early detection, monitoring, and management of heart disease. Our solutions are built on a foundation of clinical research and collaboration with leading academic institutions.
Application instructions not provided.
Non-invasive cardiac monitoring platform using AI
Cardiosense focuses on improving cardiac care through a non-invasive monitoring platform that uses biometric sensors and artificial intelligence to analyze heartbeats. This system captures the electromechanical behavior of each heartbeat, allowing for early detection of declining heart function. By providing healthcare providers with insights before symptoms arise, Cardiosense enables them to prioritize at-risk patients and take proactive measures. Unlike traditional methods that require invasive procedures, Cardiosense's approach is safer and easier for continuous monitoring. The company generates revenue by selling wearable devices and offering subscription access to its analytics platform, ensuring ongoing support for healthcare providers. The goal of Cardiosense is to enhance patient outcomes in cardiac care by preventing severe events through timely intervention.